Fluorescent, upconverting, and SERS molecules
Document Type
Article
Publication Date
1-1-2026
Abstract
The commercially available point-of-care (POC) diagnosis enterprises employ the substantial application of lateral flow assays (LFAs) owing to their affordability, simplicity for usage at the evaluation site, and sophisticated analytical functions. However, they face limitations in the detection precision and sensitivity of the analyzed substances. To overcome these challenges, it became essential to enhance signal amplification and quantification. As an outcome, numerous LFAs based on fluorescent, surface-enhanced Raman spectroscopy (SERS), and upconverting are being established; these substances are noteworthy for their prolonged shelf life and outstanding endurance. In this chapter, we discuss recent advancements in these assays that integrate high sensitivity, signal amplification, and quantification.
Publication Source (Journal or Book title)
Lateral Flow Assays for Rapid Point of Care Testing Recent Advances Emerging Trends and Future Direction
First Page
107
Last Page
134
Recommended Citation
Gupta, M., Das, S., Devireddy, R., & Gartia, M. (2026). Fluorescent, upconverting, and SERS molecules. Lateral Flow Assays for Rapid Point of Care Testing Recent Advances Emerging Trends and Future Direction, 107-134. https://doi.org/10.1016/B978-0-443-33156-5.00009-9